Great Lakes Dredge & Dock Corporation Schedules Announcement of 2019 Fourth Quarter Results
OAK BROOK, Ill., Feb. 12, 2020 (GLOBE NEWSWIRE) — Great Lakes Dredge & Dock Corporation (NASDAQ: GLDD) today announced that […]
Prothena Reports Fourth Quarter and Full Year 2019 Financial Results, and Provides Financial Guidance and R&D Update
Net cash used in operating and investing activities was $14.6 million in the fourth quarter and $53.5 million for the […]
TSX News -
The Keg Royalties Income Fund announces February 2020 cash distribution
VANCOUVER, British Columbia, Feb. 12, 2020 (GLOBE NEWSWIRE) — The Keg Royalties Income Fund (the “Fund”) (TSX: KEG.UN) today announced […]
Inspire Medical Systems, Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference
MINNEAPOLIS, Feb. 12, 2020 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on […]
Akerna Corp. Reports Second Quarter Fiscal Year 2020 Results
DENVER, Feb. 12, 2020 (GLOBE NEWSWIRE) — Akerna Corp. (Nasdaq: KERN, KERNW), a leading cannabis compliance technology provider and developer […]
Ascendis Pharma A/S Announces Upcoming Investor Presentation in February
COPENHAGEN, Denmark, Feb. 12, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative […]
Atomera Provides Fourth Quarter and Fiscal 2019 Results
LOS GATOS, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) — Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and intellectual property licensing […]
Pluralsight Announces Fourth Quarter and Year End 2019 Results
SILICON SLOPES, Utah, Feb. 12, 2020 (GLOBE NEWSWIRE) — Pluralsight, Inc. (NASDAQ: PS), the enterprise technology skills company, today announced […]
Applied Materials Announces First Quarter 2020 Results
Quarterly revenue of $4.16 billion, up 11 percent year over yearGAAP EPS of $0.96 and non-GAAP EPS of $0.98, up […]
Reata Pharmaceuticals, Inc. to Report Fourth Quarter and Full Year 2019 Financials and to Provide an Update on Development Programs on February 19, 2020
PLANO, Texas, Feb. 12, 2020 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that […]
